News & Videos

...

Meet Klara who welcomes visitors to the Parliament in Hungarian, German, French and English. Visiting the Parliament is free, ......

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company...

WATERTOWN, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), will report first quarter 2024 financial results on May 2, 2024, and will host a conference call at 8:30 a.m. ET. To access the May 2 conference call via phone, please dial +1 (833) 630-2127 (US) or +1 (412) 317-1846 (International) and ask to join the Kymera...

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Roth CH Acquisition Co. (OTCQX: USCTF), a special purpose acquisition company, has qualified to trade on the OTCQX® Best Market. Roth CH Acquisition Co. previously traded on NASDAQ. Roth CH Acquisition Co. begins trading today on OTCQX under the symbol “USCTF.” U.S. investors can find current financial...

Miami, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company") , a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results for the first quarter 2024 before the market opens on Thursday, May 9, 2024. Management will host a webcast and conference call that same day at 10:00 a.m. Eastern time to review the Company’s results....

YARDLEY, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced corporate updates detailing its commercial plans and expectations for XHANCE ® (fluticasone propionate) following the recent FDA approval of a new indication for the treatment of chronic rhinosinusitis without nasal polyps in patients 18 year of age and older. The Company will host an investor call at...

MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “ BRW ” or the “ Company ”) is pleased to report the first assays from the Mirage winter drilling campaign where it drilled an additional thirty-five holes. The Mirage Project is located in the Eeyou Istchee-James Bay region of Quebec approximately 40 kilometres south from the Trans-Taiga Road. The winter drill campaign focused on the Central Zone and has continued to intersect multiple...

MISSISSAUGA, Ontario, April 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products (“ QAPs™ ”) for accreditation of clinical labs for conducting molecular (“ MDx ”) tests for antimicrobial-resistant (“ AMR ”) strains of M. genitalium (“ Mgen ”), a...

Boston, April 25, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in the Needham Technology, Media and Consumer Conference. Robert Shepardson, Amwell chief financial officer, will participate in a fireside chat on Tuesday, May 14, at a time to be determined, along with one-on-one investor meetings throughout the day. An audio webcast of the fireside chat will be available at investors.amwell.com. About Amwell Amwell...

MALVERN, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2024 financial results on Thursday, May 9, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. First Quarter Earnings...

NEW HAVEN, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. BioXcel Therapeutics’ management team will also host a conference call and webcast at 8:00 AM ET that day to discuss...

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2024. First quarter 2024 net revenues 1 were $1.1 billion , an increase of 22% over the first quarter of 2023, up 6% organically 2 or 7% on a pro forma 3 basis, including Adenza in the first quarter of 2023 results for Nasdaq. This included Solutions 4 revenue increasing 35% , with organic growth of 11% or 13% on a pro forma basis. Annualized Recurring Revenue (ARR)...

EATONTOWN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announced the launch of a new partnership with Automox, a leading cloud-native IT automation endpoint management solution, now available to their North American partners. With the addition of Automox, Climb partners can provide customers the capabilities to save time, eliminate risk, and automate...

MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce today that it has received two separate project milestone payments totaling $970,000....

- Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET Phase 2 study of MORF-057 in patients with moderate-to-severe Crohn’s disease in second quarter- -Ended first quarter with $658.8 million in cash, cash equivalents, and marketable securities; cash runway into second half of 2027- WALTHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic...

First quarter 2024 earnings per share of $1.19 Inland marine experienced strong market conditions with a sequential increase in spot market prices and high-teens operating margins despite a sequential increase in delay days Coastal operating margins improved to high single to low double-digit range Breaking out power generation at KDS as its significance continues to grow, constituting 41% of KDS revenues Kirby repurchased 498,505 shares at an average price of $83.82 for $41.8 million in the...

ATLANTA, April 25, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY), today announced a design refresh to make the Sweetwater brand more impactful, cohesive, and memorable to consumers. SweetWater’s updated portfolio of beers is available now across the Southeast and in select national markets. The new logo and packaging are part of a...

Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose (one 8µL spray per eye) Also announces upcoming ARVO presentation on the unique technology behind clobetasol that allows for future ophthalmic suspensions to be dispensed with the Optejet® NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today provided an update on its two FDA-approved...

Continued significant investments to improve reliability and transition to cleaner generation; on track to invest more than $4 billion into our utilities in 2024 Earned the ENERGY STAR Partner of the Year award for sustained excellence in energy efficiency Celebrated 175 years of service at DTE Gas Grew MIGreenPower voluntary renewables program by enrolling Taubman Realty Group and other customers Recognized as a Gallup Exceptional Workplace for 12th consecutive year DETROIT, April 25, 2024...